Advertising Alert: FDA Offers Draft Guidance Concerning the Presentation and Correction of Information on Internet/Social Media Platforms Regarding Prescription Drugs and Medical Devices
Diversity & Community Services Mosaics Newsletter: Summer 2014
Please use the form below to search for any relevant publications pertaining to your specific needs. If you would like to be added to Kramer Levin's publications distribution list, please click onto the Publications Sign Up in the right side bar.
The Deal Pipeline published an article by Corporate partners Abbe L. Dienstag and Ernest S. Wechsler entitled “Reconsidering NDAs.” On May 4, 2012, the Delaware Court of Chancery held that Martin Marietta Materials had violated a pair of confidentiality agreements with Vulcan Materials and issued a 4-month temporary injunction suspending Martin Marietta's hostile exchange offer for Vulcan and related proxy contest. Martin Marietta has appealed the Court's decision to the Delaware Supreme Court. The case - which was decided by the Court as a pure contract case (and not as a fiduciary duty case) - has important implications for drafting transactional non-disclosure agreements. The authors discuss the Court's decision and provide some key takeaways.